Custom service

Fusion Protein Immunogenicity Testing

Test ada against fc- and albumin-fusion proteins

Turnaround: 10–14 weeksTypical scale: µg – g sample scaleChemistry options: fusion-domain ADA mapping; Fc-region interference control; titer and NAb tiers

Fusion Protein Immunogenicity Testing supports programmes that test ADA against Fc- and albumin-fusion proteins. In a typical engagement we plan the fusion-domain ADA mapping route first, confirm compatibility with Fc-region interference control, and release fusion protein immunogenicity package on a 10–14 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep fusion-domain ADA mapping as the primary option and hold Fc-region interference control in reserve, so that scale-up never depends on an unproven step.

Fc-fusion therapeutics programs

Domain-level immunogenicity attribution

Small fusion tags without clinical relevance

Samples requiring containment or licensing we do not hold (BSL-3, radioactive)

Analytical reports follow a fixed template: sample condition on receipt, method description with validation status, raw chromatograms and spectra, results with uncertainty, and an interpretation note. Urgent same-week slots are available for release-critical testing.

Service Highlights

  • Fusion-domain ADA mapping as the default route, with Fc-region interference control held as a proven fallback
  • Titer and NAb tiers worked into the design where the application requires it
  • Results are reported with detection limits and method validation status, so you know exactly what the number means
  • Analytical confirmation of every intermediate before the final release
  • Orthogonal methods are used by default — one measurement is an observation, two are data
  • Fusion protein immunogenicity package delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sample intake & plan

    Samples are logged with chain of custody and the test matrix for Fusion Protein Immunogenicity Testing is confirmed.

  2. Method selection

    Analytical methods — fusion-domain ADA mapping, Fc-region interference control — are chosen and their validation status documented.

  3. Measurement

    Testing is executed with system-suitability checks and orthogonal confirmation where required.

  4. Data review

    Chromatograms and spectra are reviewed by a second analyst before any result is issued.

  5. Reporting

    Fusion protein immunogenicity package is issued with detection limits and interpretation notes.

  6. Follow-up support

    We discuss anomalies and, where useful, propose the follow-up experiment that resolves them.

Specifications & timeline

Turnaround
10–14 weeks
Typical scale
µg – g sample scale
Chemistry options
fusion-domain ADA mapping; Fc-region interference control; titer and NAb tiers
Deliverable
Fusion protein immunogenicity package
QC package
Method report, raw data, validated result with detection limits
Shipping
Blue ice or ambient by material; chain-of-custody on receipt

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.